To determine the prevalence of insulin resistance/hyperinsulinemia and other components of the metabolic syndrome among non-obese, and obese essential hypertensives living in Buenos Aires. One hundred thirtyone hypertensives never treated or after 3 week placebo period and 31 normotensive control subjects matched for age, sex and BMI, that demonstrated normal glucose tolerance at the OGTT were included. The plasma fasting insulin (IRI) levels, the SIRI (the sum of the plasma insulin levels after the OGTT), and the Homa's index of the groups were compared. In non-elderly (agedϽ65 y) hypertensives the mean insulin value (AUC insulin ), SIRI and the AUC glucose were higher than in agedmatched normotensives (81.2Ϯ 67.2 vs 53.3Ϯ 34.3 m U/ml; 273.1Ϯ 230.7 vs 185.8Ϯ 113.8 m U/ml, and 133.4Ϯ 29.1 vs 121.8Ϯ 18.6 mg/dl, respectively, for all pϽ0.05). In non-elderly non-obese hypertensives AUC insulin was higher than in aged-sex-and weight-matched normotensives (61.5Ϯ 42 vs 37.2Ϯ 17.6 m U/ml, pϽ0.05). In overweight hypertensive men the AUC insulin and SRI were higher than in non-obese (81.3Ϯ 64.1 vs 46.9Ϯ 34.1 m U/ml; 275.7Ϯ 222.4 vs 164.3Ϯ 122.4 m U/ml, both pϽ0.05). Multiple logistic regression analysis showed age, gender and waist circumference (WC) were associated with risk of hypertension (OR: 1.05; 4.5; 4.6, respectively). Only hypertensives in the third tertile of AUC insulin had higher triglyceride levels than those in the lower tertile (pϽ0.05). Hypertensives with larger WC (men Ͼ102, womenϾ88 cm) had higher triglycerides (166.4Ϯ 70 vs 121,7Ϯ 42.5 mg/dl, pϽ0.01); AUC glucose (150.6Ϯ 32.4 vs 126,.8Ϯ 24.4 mg/dl, pϽ0.01); AUC insulin (107.8Ϯ 88.2 vs 63.8Ϯ 40.5 m U/ml, pϽ0.05) and SIRI (368.3Ϯ 305.6 vs 213.4Ϯ 135.3 m U/ml, pϽ0.01) than those with normal WC. In hypertensives IRI levels and HOMA were correlated with daytime DBP and 24-h mean DBP (pϽ0.05).
P-494 DETECTING AN RISK FACTOR OF THE METABOLIC SYNDROME IN SOUTH CAROLINA STATE UNIVERSITY FRESHMEN: OBESITY
Background: A clustering of risk factors that include obesity, hypertension, dyslipidemia and glucose intolerance are often seen in patients with cardiovascular disease (cvd) and type II diabetes. This clustering of cvd risk factors has come to be known as the metabolic syndrome. However, the specific factors that constitute the metabolic syndrome are debatable and several definitions have been established to identify this syndrome: the World Health Organization (WHO) and the National Cholesterol Education Program Treatment Panel (NCEP) use different measures of obesity in its definitions. The WHO uses total obesity measured by body mass index (BMI) as the most expressed measure of obesity in the syndrome, while NCEP includes waist circumference in its definition. It has been well established that obesity is an independent risk factor for the development of cvd and type II diabetes and that it tends to cluster with other cvd risk factors, but there is still no consensus on the appropriate or most expressed measure of obesity. The aim of this study is to evaluate measures of obesity in South Carolina State University (SCSU) freshmen with diagnosed hypertension.
Methods: To evaluate the relative association between BMI and waist circumference with hypertension, a cross-sectional study of 907 SCSU African American freshmen aged 17-19 will be conducted. Students will be given a Student Health and Behavior Survey, the cross-sectional survey addresses health and lifestyle behaviors. Data will be analyzed by calculating an odds ratio and 95% CI for the association between BMI and hypertension and for the association between waist circumference and hypertension using logistic regression to control for sex, family history, physical activity, diabetes, and the other measure of obesity. To evaluated the relationship between glucose regulation, insulin secretion and blood pressure in normotensive and hypertensive obese subjects.
We studied 12 normotensive (NT-OB) and 8 hypertensive (HT-OB) obese (BMI Ͼ 30Kg/m 2 ) men, age 36 Ϯ8 yrs. And ten healthy controls (BMI Ͻ25 kg/m 2 ) matched for age. After overnight fasting, samples for glucose and insulin were drawn at 30 min intervals during 2 h after meals (post-prandial periods) and 60 min during the rest of the 24h (between meals and during the night). AMBP (Spacelab 90207) were performed at 20 min intervals. Subjects ingested a standard diet (2100 Kcal), divided into three meals (breakfast at 8 AM, lunch at 13:30 PM and dinner at 20 PM). we studied the insulin sensitivity by Insulin Supression Test and also we calculated the ratio AUC insulin/AUC glucose in the postprandial period.
Obese patients showed significant hypersecretion of insulin in basal and post-prandial periods, especially after dinner and at night. Further-
